UNSPSC 51333404: Eltoprazine

This classification denotes a serotonin agonist with the molecular formula C12H16N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 510M006KO6, chemically known as 1-(1,4-benzodioxan-5-yl)piperazine but generally known as eltoprazine, which bears US NIH Compound Identifier 65853. European Medicines Agency schedules Eltoprazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06496MIG.

UNSPSC 51333404 Eltoprazine, a Commodity code, does not match the state and local procurement activity tagged under it. The single recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems—addresses opioid-reversal medications and harm-reduction equipment, not eltoprazine (an investigational psychiatric agent). The mismatch suggests a tagging error in the underlying procurement record rather than active state and local market demand for eltoprazine itself. State and local governments appear not to be soliciting eltoprazine under this code at this time.

The one visible solicitation is Seminole County's July 2026 IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida and a response deadline of July 26, 2023. The contract carries a two-year initial term with one-year renewal option, requires E-Verify compliance, workers' compensation and commercial general liability insurance, and potential FEMA funding with associated Clean Air Act and Federal Water Pollution Control Act compliance obligations. Bidders must include all shipping and delivery costs in their proposals and submit electronically through the county's e-Procurement Portal. No explicit set-aside designations were specified.